These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22810102)

  • 1. Highly pathogenic Alzheimer's disease presenilin 1 P117R mutation causes a specific increase in p53 and p21 protein levels and cell cycle dysregulation in human lymphocytes.
    Bialopiotrowicz E; Szybinska A; Kuzniewska B; Buizza L; Uberti D; Kuznicki J; Wojda U
    J Alzheimers Dis; 2012; 32(2):397-415. PubMed ID: 22810102
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase in p53 protein levels by presenilin 1 gene mutations and its inhibition by secretase inhibitors.
    Ma L; Ohyagi Y; Miyoshi K; Sakae N; Motomura K; Taniwaki T; Furuya H; Takeda K; Tabira T; Kira J
    J Alzheimers Dis; 2009; 16(3):565-75. PubMed ID: 19276551
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased Abeta secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1.
    Shimojo M; Sahara N; Murayama M; Ichinose H; Takashima A
    Neurosci Res; 2007 Mar; 57(3):446-53. PubMed ID: 17210196
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi.
    Xia W; Zhang J; Ostaszewski BL; Kimberly WT; Seubert P; Koo EH; Shen J; Selkoe DJ
    Biochemistry; 1998 Nov; 37(47):16465-71. PubMed ID: 9843412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial Alzheimer's Disease Lymphocytes Respond Differently Than Sporadic Cells to Oxidative Stress: Upregulated p53-p21 Signaling Linked with Presenilin 1 Mutants.
    Wojsiat J; Laskowska-Kaszub K; Alquézar C; Białopiotrowicz E; Esteras N; Zdioruk M; Martin-Requero A; Wojda U
    Mol Neurobiol; 2017 Sep; 54(7):5683-5698. PubMed ID: 27644130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle-driven neuronal apoptosis specifically linked to amyloid peptide Abeta1-42 exposure is not exacerbated in a mouse model of presenilin-1 familial Alzheimer's disease.
    Malik B; Currais A; Soriano S
    J Neurochem; 2008 Jul; 106(2):912-6. PubMed ID: 18466334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered cell cycle-related gene expression in brain and lymphocytes from a transgenic mouse model of Alzheimer's disease [amyloid precursor protein/presenilin 1 (PS1)].
    Esteras N; Bartolomé F; Alquézar C; Antequera D; Muñoz Ú; Carro E; Martín-Requero Á
    Eur J Neurosci; 2012 Sep; 36(5):2609-18. PubMed ID: 22702220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoskeletal alterations differentiate presenilin-1 and sporadic Alzheimer's disease.
    Woodhouse A; Shepherd CE; Sokolova A; Carroll VL; King AE; Halliday GM; Dickson TC; Vickers JC
    Acta Neuropathol; 2009 Jan; 117(1):19-29. PubMed ID: 19015863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell cycle regulation distinguishes lymphocytes from sporadic and familial Alzheimer's disease patients.
    Bialopiotrowicz E; Kuzniewska B; Kachamakova-Trojanowska N; Barcikowska M; Kuznicki J; Wojda U
    Neurobiol Aging; 2011 Dec; 32(12):2319.e13-26. PubMed ID: 20541838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tauroursodeoxycholic acid modulates p53-mediated apoptosis in Alzheimer's disease mutant neuroblastoma cells.
    Ramalho RM; Borralho PM; Castro RE; Solá S; Steer CJ; Rodrigues CM
    J Neurochem; 2006 Sep; 98(5):1610-8. PubMed ID: 16923170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The presenilin 1 C92S mutation increases abeta 42 production.
    Lewis PA; Perez-Tur J; Golde TE; Hardy J
    Biochem Biophys Res Commun; 2000 Oct; 277(1):261-3. PubMed ID: 11027672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presenilin-1 L166P mutant human pluripotent stem cell-derived neurons exhibit partial loss of γ-secretase activity in endogenous amyloid-β generation.
    Koch P; Tamboli IY; Mertens J; Wunderlich P; Ladewig J; Stüber K; Esselmann H; Wiltfang J; Brüstle O; Walter J
    Am J Pathol; 2012 Jun; 180(6):2404-16. PubMed ID: 22510327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of activation of caspases by presenilin 1 gene mutations and its inhibition by secretase inhibitors.
    Miyoshi K; Ohyagi Y; Sakae N; Motomura K; Ma L; Taniwaki T; Furuya H; Tabira T; Kira J
    J Alzheimers Dis; 2009; 16(3):551-64. PubMed ID: 19276550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological manifestation of the induced pluripotent stem cell-derived cortical neurons from an early-onset Alzheimer's disease patient carrying a presenilin-1 mutation (S170F).
    Li L; Kim HJ; Roh JH; Kim M; Koh W; Kim Y; Heo H; Chung J; Nakanishi M; Yoon T; Hong CP; Seo SW; Na DL; Song J
    Cell Prolif; 2020 Apr; 53(4):e12798. PubMed ID: 32216003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial Alzheimer's disease mutations inhibit gamma-secretase-mediated liberation of beta-amyloid precursor protein carboxy-terminal fragment.
    Wiley JC; Hudson M; Kanning KC; Schecterson LC; Bothwell M
    J Neurochem; 2005 Sep; 94(5):1189-201. PubMed ID: 15992373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative ratio and level of amyloid-β 42 surrogate in cerebrospinal fluid of familial Alzheimer disease patients with presenilin 1 mutations.
    Tagami S; Okochi M; Yanagida K; Kodama T; Arai T; Kuwano R; Ikeuchi T; Takeda M
    Neurodegener Dis; 2014; 13(2-3):166-70. PubMed ID: 24192669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
    Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
    FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical-genetic correlations in familial Alzheimer's disease caused by presenilin 1 mutations.
    Gómez-Tortosa E; Barquero S; Barón M; Gil-Neciga E; Castellanos F; Zurdo M; Manzano S; Muñoz DG; Jiménez-Huete A; Rábano A; Sainz MJ; Guerrero R; Gobernado I; Pérez-Pérez J; Jiménez-Escrig A
    J Alzheimers Dis; 2010; 19(3):873-84. PubMed ID: 20157243
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase in presenilin 1 (PS1) levels in senescence-accelerated mice (SAMP8) may indirectly impair memory by affecting amyloid precursor protein (APP) processing.
    Kumar VB; Franko M; Banks WA; Kasinadhuni P; Farr SA; Vyas K; Choudhuri V; Morley JE
    J Exp Biol; 2009 Feb; 212(Pt 4):494-8. PubMed ID: 19181896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.